{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:54:42Z","timestamp":1790945682638,"version":"4.1.0"},"reference-count":45,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background and purpose: High-tech medical resources play an increasingly important role in cancer diagnosis and treatment. However, accessing information about these technologies remains challenging due to their complexity and a lack of clear information pathways to obtain reliable information. This, in turn, contributes to inequalities in healthcare.\nPatient\/material and methods: The Joint Action Network of Expertise on Cancer (JANE-2) is one of the largest networks under Europe\u2019s Beating Cancer Plan. In JANE-2, the work package on High-Tech Medical Resources comprises seven domains of rapidly evolving technologies, namely Nuclear Medicine, Radiomics, Innovative Radiotherapy, Innovative Surgery, Physical Methods of Ablation, Cell Therapies, and Ex-vivo Testing of Agents. Leaders from these domains, together with patient representatives, have authored a review of the challenges of providing patients with information about high-tech medical resources, and have proposed potential solutions.\nResults: This article describes the challenges associated with providing adequate information to patients, the resulting consequences, and potential solutions. The article also specifically describes technologies related to the seven high-tech domains that are central to cancer treatment. Patient information tools related to these technologies are provided as supplementary material to the article.\nInterpretation: Cancer diagnosis and treatment are not only becoming increasingly effective but also more complex with the adoption of novel technologies. This article discusses the challenges and potential solutions related to the availability of patient information and provides examples of patient information tools for seven key and rapidly advancing technologies.<\/jats:p>","DOI":"10.2340\/1651-226x.2026.45529","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:08:30Z","timestamp":1790942910000},"page":"818-835","source":"Crossref","is-referenced-by-count":0,"title":["Tools for providing information to patients about high-tech medical resources for treatment of cancer"],"prefix":"10.2340","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3829-0210","authenticated-orcid":false,"given":"Julie","family":"Gehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0146-9236","authenticated-orcid":false,"given":"Tatiana","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Rokkones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7904-5882","authenticated-orcid":false,"given":"Soleakhena","family":"Ken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7641-5670","authenticated-orcid":false,"given":"Gregor","family":"Sersa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4612-4629","authenticated-orcid":false,"given":"Irene","family":"Torres-Espallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-8574","authenticated-orcid":false,"given":"Ester","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1870-3380","authenticated-orcid":false,"given":"Laura","family":"Ridolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Kruecken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Haag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5147-0473","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Garcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5366-1254","authenticated-orcid":false,"given":"Anne-Laure","family":"Giraudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Lavall\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2532-9422","authenticated-orcid":false,"given":"Colin Patrick","family":"Cantwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1284-2638","authenticated-orcid":false,"given":"Alexander Jorge","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8492-3551","authenticated-orcid":false,"given":"Chiara","family":"Marazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-0355","authenticated-orcid":false,"given":"Roger","family":"Olofsson Bagge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-0890","authenticated-orcid":false,"given":"Massimiliano","family":"Petrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1544-9911","authenticated-orcid":false,"given":"Francesca","family":"Bonifazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2631-0029","authenticated-orcid":false,"given":"Vincent","family":"Bourbonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-2362","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Courbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-7896","authenticated-orcid":false,"given":"Ibrahim","family":"Edhemovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0623-4118","authenticated-orcid":false,"given":"Lisa","family":"Licitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6459-2613","authenticated-orcid":false,"given":"Sergio","family":"Roman-Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-120X","authenticated-orcid":false,"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"170006","doi-asserted-by":"crossref","unstructured":"Bogdanovic B, Hugonnet F, Montemagno C. Theranostics in hematological malignancies: cutting-edge advances in diagnosis and targeted therapy. Cancers (Basel). 2025;17(7):1247.","DOI":"10.3390\/cancers17071247"},{"key":"170007","doi-asserted-by":"crossref","unstructured":"Burkett BJ, Bartlett DJ, McGarrah PW, Lewis AR, Johnson DR, Berberoglu K, et al. A review of theranostics: perspectives on emerging approaches and clinical advancements. Radiol Imaging Cancer. 2023;5(4):e220157.","DOI":"10.1148\/rycan.220157"},{"key":"170008","doi-asserted-by":"crossref","unstructured":"Currie G. Molecular theranostics: principles, challenges and controversies. J Med Radiat Sci. 2025;72(1):156\u201364.","DOI":"10.1002\/jmrs.836"},{"key":"170009","doi-asserted-by":"crossref","unstructured":"Abdel-Wahab M, Giammarile F, Carrara M, Paez D, Hricak H, Ayati N, et al. Radiotherapy and theranostics: a Lancet Oncology Commission. Lancet Oncol. 2024;25(11):e545\u201380.","DOI":"10.1016\/S1470-2045(24)00407-8"},{"key":"170010","doi-asserted-by":"crossref","unstructured":"Bodei L, Herrmann K, Schoder H, Scott AM, Lewis JS. Radiotheranostics in oncology: current challenges and emerging opportunities. Nat Rev Clin Oncol. 2022;19(8):534\u201350.","DOI":"10.1038\/s41571-022-00652-y"},{"key":"170011","doi-asserted-by":"crossref","unstructured":"Kocak B, Akinci D\u2019Antonoli T, Mercaldo N, Alberich-Bayarri A, Baessler B, Ambrosini I, et al. METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII. Insights Imaging. 2024;15(1):8.","DOI":"10.1186\/s13244-023-01572-w"},{"key":"170012","doi-asserted-by":"crossref","unstructured":"Zwanenburg A, Vallieres M, Abdalah MA, Aerts H, Andrearczyk V, Apte A, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295(2):328\u201338.","DOI":"10.1148\/radiol.2020191145"},{"key":"170013","doi-asserted-by":"crossref","unstructured":"Lambin P, Woodruff HC, Mali SA, Zhong X, Kuang S, Lavrova E, et al. Radiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine. Nat Rev Clin Oncol. 2025;22(11):831\u201346.","DOI":"10.1038\/s41571-025-01067-1"},{"key":"170014","doi-asserted-by":"crossref","unstructured":"Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, et al. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol. 2020;21(1):e18\u201328.","DOI":"10.1016\/S1470-2045(19)30718-1"},{"key":"170015","doi-asserted-by":"crossref","unstructured":"Ng J, Gregucci F, Pennell RT, Nagar H, Golden EB, Knisely JPS, et al. MRI-LINAC: a transformative technology in radiation oncology. Front Oncol. 2023;13:1117874.","DOI":"10.3389\/fonc.2023.1117874"},{"key":"170016","doi-asserted-by":"crossref","unstructured":"Durante M, Loeffler JS. Charged particles in radiation oncology. Nat Rev Clin Oncol. 2010;7(1):37\u201343.","DOI":"10.1038\/nrclinonc.2009.183"},{"key":"170017","doi-asserted-by":"crossref","unstructured":"Wilson JD, Hammond EM, Higgins GS, Petersson K. Corrigendum: ultra-high dose rate (FLASH) radiotherapy: silver bullet or fool\u2019s gold? Front Oncol. 2020;10:210.","DOI":"10.3389\/fonc.2020.00210"},{"key":"170018","doi-asserted-by":"crossref","unstructured":"Gustafsson UO, Scott MJ, Hubner M, Nygren J, Demartines N, Francis N, et al. Guidelines for perioperative care in elective colorectal surgery: enhanced recovery after surgery (ERAS((R))) society recommendations: 2018. World J Surg. 2019;43(3):659\u201395.","DOI":"10.1007\/s00268-018-4844-y"},{"key":"170019","doi-asserted-by":"crossref","unstructured":"Gervaso L, Ciardiello D, Oliveira RA, Borghesani M, Guidi L, Benini L, et al. Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe? J Immunother Cancer. 2024;12(5):e008027.","DOI":"10.1136\/jitc-2023-008027"},{"key":"170020","doi-asserted-by":"crossref","unstructured":"Leite JS. Rectal cancer \u2013 avoiding surgery? Colorectal Dis. 2024;26 (2):383\u20135.","DOI":"10.1111\/codi.16854"},{"key":"170021","doi-asserted-by":"crossref","unstructured":"Pittacolo M, Khoma O, Lagarde SM, Mostert B, Wijnhoven BPL. Organ-sparing approach after neoadjuvant treatment in oesophageal cancer. Dig Surg. 2025;42(5):247\u201356.","DOI":"10.1159\/000547632"},{"key":"170022","doi-asserted-by":"crossref","unstructured":"Ma L, Fan Z, Ning G, Zhang X, Liao H. 3D visualization and augmented reality for orthopedics. Adv Exp Med Biol. 2018;1093:193\u2013205.","DOI":"10.1007\/978-981-13-1396-7_16"},{"key":"170023","doi-asserted-by":"crossref","unstructured":"Perin A, Gambatesa E, Rui CB, Carone G, Fanizzi C, Lombardo FM, et al. The \u2018STARS\u2019 study: advanced preoperative rehearsal and intraoperative navigation in neurosurgical oncology. J Neurosurg Sci. 2023;67(6):671\u20138.","DOI":"10.23736\/S0390-5616.22.05516-3"},{"key":"170024","doi-asserted-by":"crossref","unstructured":"Fan X, Liu X, Xia Q, Chen G, Cheng J, Shi Z, et al. Advanced image-guidance and surgical-navigation techniques for real-time visualized surgery. Adv Sci (Weinh). 2025;12(41):e09294.","DOI":"10.1002\/advs.202509294"},{"key":"170025","doi-asserted-by":"crossref","unstructured":"Di Giorgio A, Macri A, Ferracci F, Robella M, Visaloco M, De Manzoni G, et al. 10 years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis. Cancers (Basel). 2023;15(4):1125.","DOI":"10.3390\/cancers15041125"},{"key":"170026","doi-asserted-by":"crossref","unstructured":"Tonello M, Cenzi C, Pizzolato E, Martini M, Pilati P, Sommariva A. National guidelines for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal malignancies: a worldwide systematic review and recommendations of strength analysis. Ann Surg Oncol. 2025;32(8):5795\u2013806.","DOI":"10.1245\/s10434-025-17518-z"},{"key":"170027","doi-asserted-by":"crossref","unstructured":"Yang T, Ng DM, Du N, He N, Dai X, Chen P, et al. HIFU for the treatment of difficult colorectal liver metastases with unsuitable indications for resection and radiofrequency ablation: a phase I clinical trial. Surg Endosc. 2021;35(5):2306\u201315.","DOI":"10.1007\/s00464-020-07644-y"},{"key":"170028","doi-asserted-by":"crossref","unstructured":"Li H, Han Z, Wu H, Musaev ER, Lin Y, Li S, et al. Artificial intelligence in surgery: evolution, trends, and future directions. Int J Surg. 2025;111(2):2101\u201311.","DOI":"10.1097\/JS9.0000000000002159"},{"key":"170029","doi-asserted-by":"crossref","unstructured":"Prien C, Lincango EP, Holubar SD. Big data in surgery. Surg Clin North Am. 2023;103(2):219\u201332.","DOI":"10.1016\/j.suc.2022.12.002"},{"key":"170030","doi-asserted-by":"crossref","unstructured":"Gehl J, Pereira PL, Cantwell CP, Deschamps F, Kocijancic A, Schmidt N, et al. Tumor ablation: emerging uses, challenges, and strategic implementation. A green paper by the Network of Expertise in Cancer (JANE-2), high tech medical resources, network on physical methods of tumor ablation. Radiol Oncol. 2026;60:153\u201365.","DOI":"10.2478\/raon-2026-0030"},{"key":"170031","doi-asserted-by":"crossref","unstructured":"van der Lei S, Puijk RS, Dijkstra M, Schulz HH, Vos DJW, De Vries JJJ, et al. Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial. Lancet Oncol. 2025;26(2):187\u201399.","DOI":"10.1016\/S1470-2045(24)00660-0"},{"key":"170032","doi-asserted-by":"crossref","unstructured":"Dong F, Wu Y, Li W, Li X, Zhou J, Wang B, et al. Advancements in microwave ablation for tumor treatment and future directions. iScience. 2025;28(4):112175.","DOI":"10.1016\/j.isci.2025.112175"},{"key":"170033","doi-asserted-by":"crossref","unstructured":"Kwak K, Yu B, Lewandowski RJ, Kim DH. Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation. Theranostics. 2022;12(5):2175\u2013204.","DOI":"10.7150\/thno.67530"},{"key":"170034","doi-asserted-by":"crossref","unstructured":"Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, et al. Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008\u20132019). Eur J Cancer. 2020;138:30\u201340.","DOI":"10.1016\/j.ejca.2020.06.020"},{"key":"170035","doi-asserted-by":"crossref","unstructured":"Bachu VS, Kedda J, Suk I, Green JJ, Tyler B. High-intensity focused ultrasound: a review of mechanisms and clinical applications. Ann Biomed Eng. 2021;49(9):1975\u201391.","DOI":"10.1007\/s10439-021-02833-9"},{"key":"170036","doi-asserted-by":"crossref","unstructured":"Rhim H, Lim HK. Radiofrequency ablation of hepatocellular carcinoma: pros and cons. Gut Liver. 2010;4(Suppl 1):S113\u20138.","DOI":"10.5009\/gnl.2010.4.S1.S113"},{"key":"170037","unstructured":"European Medicines Agency. Advanced therapy medicinal products: overview. The European Union; 2026. [cited 2026 Feb 24]. Available from: https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/advanced-therapy-medicinal-products-overview?utm_source=copilot.com."},{"key":"170038","doi-asserted-by":"crossref","unstructured":"Patel KK, Tariveranmoshabad M, Kadu S, Shobaki N, June C. From concept to cure: the evolution of CAR-T cell therapy. Mol Ther. 2025;33(5):2123\u201340.","DOI":"10.1016\/j.ymthe.2025.03.005"},{"key":"170039","doi-asserted-by":"crossref","unstructured":"Goncalves E. CAR-T cell therapies: patient access and affordability solutions. Future Sci OA. 2025;11(1):2483613.","DOI":"10.1080\/20565623.2025.2483613"},{"key":"170040","doi-asserted-by":"crossref","unstructured":"Cechova Z, Kubatova J, Bartova A, Jamarik J, Samek J. beyond reimbursement status: availability of advanced therapy medicinal products across the European Union. Ther Innov Regul Sci. 2025;59(4):728\u201336.","DOI":"10.1007\/s43441-025-00769-z"},{"key":"170041","unstructured":"U.S. Food & Drug Administration. FDA approves first cellular therapy to treat patients with unresectable or metastatic melanoma. U.S. Food & Drug Administration; 2024. [cited 2026 May 21]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-cellular-therapy-treat-patients-unresectable-or-metastatic-melanoma?utm_source=copilot.com"},{"key":"170042","doi-asserted-by":"crossref","unstructured":"Spiro Z, El-Heliebi A, Mair MJ, Pieber TR, Prietl B, Spiegl-Kreinecker S, et al. Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges. Cancer Treat Rev. 2026;143:103072.","DOI":"10.1016\/j.ctrv.2025.103072"},{"key":"170043","doi-asserted-by":"crossref","unstructured":"Ahmed A, Cox E, Lane L, Rominiyi O, Danson S, Bryant HE, et al. Ex vivo drug screening: an emerging paradigm in the treatment of childhood cancer. J Pediatr Hematol Oncol. 2025;47(5):e144\u201354.","DOI":"10.1097\/MPH.0000000000003017"},{"key":"170044","doi-asserted-by":"crossref","unstructured":"Liebers N, Bruch PM, Terzer T, Hernandez-Hernandez M, Paramasivam N, Fitzgerald D, et al. Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial. Nat Cancer. 2023;4(12):1648\u201359.","DOI":"10.1038\/s43018-023-00645-5"},{"key":"170045","doi-asserted-by":"crossref","unstructured":"Moyer AM, Madsen H, Johnson J, Del Chiaro M, Gleisner A, Lieu CH, et al. Informational needs of surgical oncology patients: a cross-sectional patient survey. J Surg Res. 2023;283:771\u20137.","DOI":"10.1016\/j.jss.2022.11.027"},{"key":"170046","doi-asserted-by":"crossref","unstructured":"Donovan JL, Hamdy FC, Lane JA, Mason M, Metcalfe C, Walsh E, et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2016;375(15):1425\u201337.","DOI":"10.1056\/NEJMoa1606221"},{"key":"170047","doi-asserted-by":"crossref","unstructured":"Vestergaard K, Vissing M, Gehl J, Lindhardt CL. Qualitative investigation of experience and quality of life in patients treated with calcium electroporation for cutaneous metastases. Cancers (Basel). 2023;15(3):599.","DOI":"10.3390\/cancers15030599"},{"key":"170048","doi-asserted-by":"crossref","unstructured":"Taylor C, Finnegan-John J, Green JS. \u2018No decision about me without me\u2019 in the context of cancer multidisciplinary team meetings: a qualitative interview study. BMC Health Serv Res. 2014;14:488.","DOI":"10.1186\/PREACCEPT-1356081996125743"},{"key":"170049","doi-asserted-by":"crossref","unstructured":"McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 2009;374(9695):1105\u201312.","DOI":"10.1016\/S0140-6736(09)61116-8"},{"key":"170050","doi-asserted-by":"crossref","unstructured":"Martin Agudo M, Van der Pol H, Bratseth Stav G, Kringelbach T, Puco K, Flobak A, et al. \u2018Crossing borders\u2019 in data standardisation: application of OMOP CDM in an international clinical trial network in precision cancer medicine. Acta Oncol. 2026;65:159\u201363.","DOI":"10.2340\/1651-226X.2026.45120"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/45529\/55705","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/45529\/55705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:08:38Z","timestamp":1790942918000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/45529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":45,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2026.45529","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]}}}